Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma × Aspirin × Clear all

Sponsor

Conditions

Multiple Myeloma 4 Colorectal Neoplasms 4 Barrett Esophagus 3 Venous Thromboembolism 2 Tobacco Use Disorder 2 Prostatic Neoplasms 2 Precancerous Conditions 2 Polycythemia Vera 2 Myocardial Infarction 2 Esophageal Neoplasms 2 Colonic Neoplasms 2 Breast Neoplasms 2 Vascular Diseases 1 Triple Negative Breast Neoplasms 1 Thromboembolism 1 Thrombocytopenia 1 Thrombocythemia, Essential 1 Stroke 1 Soft Tissue Neoplasms 1 Smoking Cessation 1 Sarcoma 1 Rectal Neoplasms 1 Ovarian Neoplasms 1 Node Positive HER2 Negative Breast Cancer 1 Neoplasms, Plasma Cell 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 Myocardial Ischemia 1 Myeloproliferative Disorders 1 Multiple Pulmonary Nodules 1

Interventions

Carboplatin 23 Cisplatin 19 pembrolizumab 13 Paclitaxel 12 Gemcitabine 12 Pemetrexed 11 130-nm albumin-bound paclitaxel 9 Everolimus 8 Cetuximab 8 Fluorouracil 7 Axitinib 6 osimertinib 5 durvalumab 5 Sunitinib 5 Radiotherapy 5 Erlotinib Hydrochloride 5 Docetaxel 5 Cyclophosphamide 5 Albumin-Bound Paclitaxel 5 Sorafenib 4 Radiation 4 Nivolumab 4 Ipilimumab 4 vosaroxin 3 Radiotherapy, Intensity-Modulated 3 Octreotide 3 Irinotecan 3 Bevacizumab 3 1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 3 pralsetinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡